Cart
sales@molnova.com
ML337
CAS No. 1443118-44-2
ML337 ( ML 337 )
Catalog No. M27661 CAS No. 1443118-44-2
negative allosteric modulator of mGlu3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 88 | Get Quote |
|
| 10MG | 155 | Get Quote |
|
| 25MG | 327 | Get Quote |
|
| 50MG | 489 | Get Quote |
|
| 100MG | 705 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameML337
-
NoteResearch use only, not for human use.
-
Brief Descriptionnegative allosteric modulator of mGlu3.
-
Descriptionnegative allosteric modulator of mGlu3.
-
SynonymsML 337
-
PathwayOthers
-
TargetOther Targets
-
RecptorTryptophan hydroxylase;5-HT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1443118-44-2
-
Formula Weight353.4
-
Molecular FormulaC21H20FNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]1(O)CCCN(C1)C(=O)c1ccc(cc1F)C#Cc1ccc(OC)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fabio Bellia, et al. Transient serotonin depletion at adolescence, but not at early infancy, reduced subsequent anxiety-like behavior and alcohol intake in female mice. Psychopharmacology (Berl). 2021 Jan;238(1):215-225.
molnova catalog
related products
-
DCZ0415
DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.
-
3-TERT-BUTYL-4-HYDRO...
3-tert-Butyl-p-hydroxyanisole is an antioxidant which is produced via water chlorination.
-
SBC-115337
SBC-115337 is a PCSK9 inhibitor.
